Publications by authors named "Philipp Steiner"

Claim this Profile
M
mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity.
Christopher J Nirschl, Heather R Brodkin, Celesztina Domonkos, Connor J Dwyer, Daniel J Hicklin, Philipp Steiner

Cancer Immunol Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting microbial water quality in on-site water reuse systems with online sensors.
Eva Reynaert, Philipp Steiner, Qixing Yu, Lukas D'Olif, Noah Joller

Water Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Conditionally Activated IL-2 that Promotes Antitumor Immunity and Induces Tumor Regression.
Christopher J Nirschl, Heather R Brodkin, Daniel J Hicklin, Nesreen Ismail, Kristin Morris, Philipp Steiner

Cancer Immunol Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of ASP8374, a fully-human, antagonistic anti-TIGIT monoclonal antibody.
Kenna Shirasuna, Gerald Koelsch, Cynthia Seidel-Dugan, Andres Salmeron, Philipp Steiner

Cancer Treat Res Commun· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Potent HER3 Monoclonal Antibody That Blocks Both Ligand-Dependent and -Independent Activities: Differential Impacts of PTEN Status on Tumor Response.
Zhan Xiao, Rosa A Carrasco, Kevin Schifferli, Krista Kinneer, Ravinder Tammali, Philipp Steiner

Mol Cancer Ther· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual implantable electronic device therapy.
Sebastian Reif, Philipp Steiner, Ellen Hoffmann

Europace· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods for evaluating effects of an irinotecan + 5-fluorouracil/leucovorin (IFL) regimen in an orthotopic metastatic colorectal cancer model utilizing in vivo bioluminescence imaging.
David Surguladze, Philipp Steiner, Marie Prewett, James R Tonra

Methods Mol Biol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prioritization of EGFR/IGF-IR/VEGFR2 combination targeted therapies utilizing cancer models.
James R Tonra, Erik Corcoran, Dhanvanthri S Deevi, Philipp Steiner, Jessica Kearney

Anticancer Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory activity of cetuximab on epidermal growth factor receptor mutations in non small cell lung cancers.
Jacqueline F Doody, Ying Wang, Sheetal N Patel, Christopher Joynes, Sui Ping Lee, Philipp Steiner

Mol Cancer Ther· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor growth inhibition with cetuximab and chemotherapy in non-small cell lung cancer xenografts expressing wild-type and mutated epidermal growth factor receptor.
Philipp Steiner, Christopher Joynes, Rajiv Bassi, Su Wang, James R Tonra

Clin Cancer Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth.
Pirjo Laakkonen, Marika Waltari, Tanja Holopainen, Takashi Takahashi, Bronislaw Pytowski, Philipp Steiner

Cancer Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications.
Yolanda Fernández, Monique Verhaegen, Thomas P Miller, Jenny L Rush, Philipp Steiner

Cancer Res· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic target.
Nick Loizos, Yan Xu, Jim Huber, Meilin Liu, Dan Lu, Philipp Steiner

Mol Cancer Ther· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential apoptotic response to the proteasome inhibitor Bortezomib [VELCADE, PS-341] in Bax-deficient and p21-deficient colon cancer cells.
Jian Yu, Sagarika Tiwari, Philipp Steiner, Lin Zhang

Cancer Biol Ther· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroendocrine tumors and second primary malignancy--a relationship with clinical impact?
Rupert Prommegger, Christian Ensinger, Philipp Steiner, Tonja Sauper, Christoph Profanter

Anticancer Res· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis